Stock 002038 BEIJING SL PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing SL Pharmaceutical Co., Ltd.

Equities

002038

CNE000001L31

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
8.24 CNY +3.13% Intraday chart for Beijing SL Pharmaceutical Co., Ltd. -0.72% -19.14%
Apr. 23 Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Business Summary

Beijing SL Pharmaceutical Co., Ltd. specializes in manufacturing and marketing medicines produced by genetic engineering. Products are primarily for treating neutropenia, thrombocytopenia, renal cancer, melanoma and chronic skin ulcer.

Number of employees: 757

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical
59.0 %
496 47.3 % 601 59.0 % +21.04%
Biological, Biochemical and Pharmaceutical
39.0 %
517 49.2 % 397 39.0 % -23.27%
Others
2.0 %
37 3.5 % 21 2.0 % -43.58%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,050 100.0 % 1,018 100.0 % -3.03%

Managers

Managers TitleAgeSince
Ming Bo Xu CEO
 Chief Executive Officer 60 06-06-10
Li Ji DFI
 Director of Finance/CFO 43 23-04-23
Shu Jie Liang BRD
 Director/Board Member 58 06-04-10
Yang Wen IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Ming Bo Xu CEO
 Chief Executive Officer 60 06-06-10
Shu Jie Liang BRD
 Director/Board Member 58 06-04-10
Yu Lin Chen BRD
 Director/Board Member 79 06-04-10
Wen Xin Wang BRD
 Director/Board Member 58 13-05-15
Yan Ming Qi CHM
 Chairman 54 15-05-27
Zhong Fan Yang BRD
 Director/Board Member 55 12-05-22
Long Yun Chen BRD
 Director/Board Member 64 21-05-25
Xue Xin Zhu BRD
 Director/Board Member 58 23-05-24
Ling Jia Qian BRD
 Director/Board Member 69 21-05-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,027,350,000 592,889,960 ( 57.71 %) 0 57.71 %

Shareholders

NameEquities%Valuation
City of Xinxiang
18.75 %
159,739,970 18.75 % 194 M ¥
Ming Bo Xu
6.817 %
58,064,077 6.817 % 71 M ¥
Huo Lin Chen
1.700 %
14,477,209 1.700 % 18 M ¥
Ren Bao Lu
1.179 %
10,038,419 1.179 % 12 M ¥
GF Fund Management Co., Ltd.
0.7684 %
6,544,759 0.7684 % 8 M ¥
Yan Li Xiao
0.7001 %
5,963,500 0.7001 % 7 M ¥
Da Cheng Fund Management Co., Ltd.
0.6147 %
5,236,050 0.6147 % 6 M ¥
Bin Wang
0.5778 %
4,921,400 0.5778 % 6 M ¥
Zhuang Ping Huang
0.5722 %
4,873,733 0.5722 % 6 M ¥
HuaAn Fund Management Co., Ltd.
0.4406 %
3,753,000 0.4406 % 5 M ¥
NameEquities%Valuation
Ming Bo Xu
99.09 %
174,342,230 99.09 % 212 M ¥

Holdings

NameEquities%Valuation
SHOUYAO HOLDINGS (BEIJING) CO., LTD.
11.72%
 6,364,279 11.72% 46,855,158 $

Company contact information

Beijing SL Pharmaceutical Co., Ltd.

Building 1, Bitong Park 69 Fushi Road

100143, Beijing

+

http://www.slpharm.com.cn
address Beijing SL Pharmaceutical Co., Ltd.(002038)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8.24 CNY
Average target price
12 CNY
Spread / Average Target
+45.63%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BEIJING SL PHARMACEUTICAL CO., LTD. Stock Beijing SL Pharmaceutical Co., Ltd.
-19.14% 1.17B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.94% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.57% 233B
NOVARTIS AG Stock Novartis AG
+5.67% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-10.14% 193B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 143B
AMGEN INC. Stock Amgen Inc.
-6.47% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002038 Stock
  4. Company Beijing SL Pharmaceutical Co., Ltd.